These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11905688)

  • 1. Tamoxifen: a personal retrospective.
    Jordan VC
    Lancet Oncol; 2000 Sep; 1(1):43-9. PubMed ID: 11905688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four decades of discovery in breast cancer research and treatment--an interview with V. Craig Jordan. Interview by Marc Poirot.
    Jordan VC
    Int J Dev Biol; 2011; 55(7-9):703-12. PubMed ID: 22161827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen: catalyst for the change to targeted therapy.
    Jordan VC
    Eur J Cancer; 2008 Jan; 44(1):30-8. PubMed ID: 18068350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer.
    Jordan VC
    Br J Pharmacol; 2006 Jan; 147 Suppl 1(Suppl 1):S269-76. PubMed ID: 16402113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen treatment for breast cancer: concept to gold standard.
    Jordan VC
    Oncology (Williston Park); 1997 Feb; 11(2 Suppl 1):7-13. PubMed ID: 9065921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Task force cautious about chemoprevention. Official guidelines are out about taking tamoxifen and raloxifene to prevent breast cancer. These drugs can help, but they aren't for everyone.
    Harv Womens Health Watch; 2002 Oct; 10(2):1-2. PubMed ID: 12393316
    [No Abstract]   [Full Text] [Related]  

  • 7. Tamoxifen, raloxifene and the prevention of breast cancer.
    Bentrem DJ; Craig Jordan V
    Minerva Endocrinol; 2002 Jun; 27(2):127-39. PubMed ID: 11961504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of selective estrogen receptor modulators on breast cancer: from tamoxifen to raloxifene.
    Lee WL; Cheng MH; Chao HT; Wang PH
    Taiwan J Obstet Gynecol; 2008 Mar; 47(1):24-31. PubMed ID: 18400579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endocrine prevention of breast cancer.
    Howell A
    Best Pract Res Clin Endocrinol Metab; 2008 Aug; 22(4):615-23. PubMed ID: 18971122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal interventions to prevent hormonal cancers: breast and prostate cancers.
    Dunn BK; Ford LG
    Eur J Cancer Prev; 2007 Jun; 16(3):232-42. PubMed ID: 17415094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention of breast cancer.
    Dalton RR; Kallab AM
    South Med J; 2001 Jan; 94(1):7-15. PubMed ID: 11213947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial safety: a key hurdle for selective estrogen receptor modulators in development.
    Pinkerton JV; Goldstein SR
    Menopause; 2010; 17(3):642-53. PubMed ID: 20107426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New developments in the hormonal treatment of breast cancer in postmenopausal women].
    Trunet P; Marty M
    Bull Cancer; 1999 Oct; 86(10):815-20. PubMed ID: 10572232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimising endocrine approaches for the chemoprevention of breast cancer beyond the Study of Tamoxifen and Raloxifene (STAR) trial.
    Jordan VC
    Eur J Cancer; 2006 Nov; 42(17):2909-13. PubMed ID: 17064889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endocrine therapy for breast cancer: past and present].
    Zhang Y; Liu Y
    Zhonghua Yi Shi Za Zhi; 2015 Jan; 45(1):28-32. PubMed ID: 26268256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Additional effect of SERM: mammary gland].
    Kurebayashi J
    Clin Calcium; 2004 Oct; 14(10):47-51. PubMed ID: 15577131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The study of tamoxifen and raloxifene: preliminary enrollment data from a randomized breast cancer risk reduction trial.
    Vogel VG; Costantino JP; Wickerham DL; Cronin WM; Wolmark N
    Clin Breast Cancer; 2002 Jun; 3(2):153-9. PubMed ID: 12123540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raloxifene works as well as tamoxifen in preventing invasive breast cancer.
    Mayo Clin Womens Healthsource; 2006 Oct; 10(10):3. PubMed ID: 16977270
    [No Abstract]   [Full Text] [Related]  

  • 19. NICE recommends preventive drugs for breast cancer.
    Wise J
    BMJ; 2013 Jun; 346():f4116. PubMed ID: 23801701
    [No Abstract]   [Full Text] [Related]  

  • 20. Tamoxifen: a most unlikely pioneering medicine.
    Jordan VC
    Nat Rev Drug Discov; 2003 Mar; 2(3):205-13. PubMed ID: 12612646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.